JP2020533402A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533402A5 JP2020533402A5 JP2020532541A JP2020532541A JP2020533402A5 JP 2020533402 A5 JP2020533402 A5 JP 2020533402A5 JP 2020532541 A JP2020532541 A JP 2020532541A JP 2020532541 A JP2020532541 A JP 2020532541A JP 2020533402 A5 JP2020533402 A5 JP 2020533402A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- pharmaceutical composition
- nhch
- acceptable salt
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002193 Pain Diseases 0.000 claims description 70
- 150000001875 compounds Chemical class 0.000 claims description 66
- 230000000202 analgesic effect Effects 0.000 claims description 25
- 239000000126 substance Substances 0.000 claims description 24
- 150000003839 salts Chemical class 0.000 claims description 21
- 239000008194 pharmaceutical composition Substances 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- 208000004296 neuralgia Diseases 0.000 claims description 6
- 208000021722 neuropathic pain Diseases 0.000 claims description 6
- 125000001188 haloalkyl group Chemical group 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 206010019851 Hepatotoxicity Diseases 0.000 claims description 4
- 125000005037 alkyl phenyl group Chemical group 0.000 claims description 4
- 125000006277 halobenzyl group Chemical group 0.000 claims description 4
- 230000007686 hepatotoxicity Effects 0.000 claims description 4
- 231100000304 hepatotoxicity Toxicity 0.000 claims description 4
- 238000001727 in vivo Methods 0.000 claims description 4
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 2
- URNSECGXFRDEDC-UHFFFAOYSA-N N-acetyl-1,4-benzoquinone imine Chemical compound CC(=O)N=C1C=CC(=O)C=C1 URNSECGXFRDEDC-UHFFFAOYSA-N 0.000 claims description 2
- 208000001294 Nociceptive Pain Diseases 0.000 claims description 2
- 230000001754 anti-pyretic effect Effects 0.000 claims description 2
- 239000002221 antipyretic Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 206010003246 arthritis Diseases 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Substances [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 230000000472 traumatic effect Effects 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 19
- 0 CCCC(*)c1ccc(*)cc1 Chemical compound CCCC(*)c1ccc(*)cc1 0.000 description 2
- GABPYKHMVCJJGG-HOOMCHABSA-N CC([C@@H](C)N(CN)/C=C\C)C#C Chemical compound CC([C@@H](C)N(CN)/C=C\C)C#C GABPYKHMVCJJGG-HOOMCHABSA-N 0.000 description 1
- GIFIVFGNDCWFPS-OQTVUXTASA-N C[C@H](CC(C)=O)[C@H](CC1[C@H](C)C1)N Chemical compound C[C@H](CC(C)=O)[C@H](CC1[C@H](C)C1)N GIFIVFGNDCWFPS-OQTVUXTASA-N 0.000 description 1
- 206010065016 Post-traumatic pain Diseases 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762550137P | 2017-08-25 | 2017-08-25 | |
| US62/550,137 | 2017-08-25 | ||
| PCT/US2018/022029 WO2019040122A1 (en) | 2017-08-25 | 2018-03-12 | COMPOSITIONS AND METHODS FOR ALLEVIATING PAIN |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020533402A JP2020533402A (ja) | 2020-11-19 |
| JP2020533402A5 true JP2020533402A5 (enExample) | 2021-04-15 |
| JP7116792B2 JP7116792B2 (ja) | 2022-08-10 |
Family
ID=65439193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532541A Active JP7116792B2 (ja) | 2017-08-25 | 2018-03-12 | 疼痛を緩和するための組成物および方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11458142B2 (enExample) |
| EP (1) | EP3672938B1 (enExample) |
| JP (1) | JP7116792B2 (enExample) |
| KR (1) | KR102584483B1 (enExample) |
| CN (1) | CN111278805B (enExample) |
| AU (1) | AU2018319549C1 (enExample) |
| BR (1) | BR112020003705B1 (enExample) |
| CA (1) | CA3073801C (enExample) |
| ES (1) | ES2965542T3 (enExample) |
| HR (1) | HRP20231564T1 (enExample) |
| HU (1) | HUE066993T2 (enExample) |
| MX (1) | MX2020002147A (enExample) |
| PL (1) | PL3672938T3 (enExample) |
| RS (1) | RS65171B1 (enExample) |
| SM (1) | SMT202400050T1 (enExample) |
| WO (2) | WO2019040122A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019040122A1 (en) * | 2017-08-25 | 2019-02-28 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | COMPOSITIONS AND METHODS FOR ALLEVIATING PAIN |
| WO2021211681A1 (en) * | 2020-04-15 | 2021-10-21 | Neumentum, Inc. | Compositions and methods for treating pain and/or inflammation |
| WO2024191741A1 (en) * | 2023-03-10 | 2024-09-19 | South Rampart Pharma | Nanoparticle formulations for a non-opioid drug |
| WO2025067475A1 (zh) * | 2023-09-28 | 2025-04-03 | 四川大学华西医院 | 一类镇痛的化合物及其制备方法和用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2822827B1 (fr) | 2001-03-28 | 2003-05-16 | Sanofi Synthelabo | Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant |
| US6806291B1 (en) | 2003-10-09 | 2004-10-19 | The Foundation For The Lsu Health Sciences Center | Analgesic compounds, their synthesis and pharmaceutical compositions containing them |
| EP2056850A4 (en) * | 2006-08-08 | 2011-10-12 | Univ Louisiana State | THERAPEUTIC PROCEDURES FOR NEUROPATHIC PAIN |
| CL2008000835A1 (es) * | 2007-03-23 | 2008-10-03 | Icagen Inc Pfizer Ltd | Compuestos derivados de sulfonamidas, inhibidores de los canales de calcio; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor, sindrome de intestino irritable, enfermedad de crohn, taquiarritm |
| CN102341380A (zh) | 2009-01-22 | 2012-02-01 | 神经病治疗药物股份有限公司 | 布美他尼、呋塞米、吡咯他尼、佐塞米和托拉塞米类似物、组合物和使用方法 |
| JP2011231094A (ja) | 2009-11-02 | 2011-11-17 | Neurotherapeutics Pharma Inc | ブメタニド、フロセミド、ピレタニド、アゾセミド、およびトルセミドのアナログ、組成物および使用方法 |
| CN104230762B (zh) * | 2014-08-28 | 2016-01-13 | 青岛农业大学 | 一种含酰胺基团的苯磺酰胺类化合物及其制备和应用 |
| WO2017034872A1 (en) * | 2015-08-25 | 2017-03-02 | Janssen Pharmaceutica Nv | Indazole derivatives useful as cb-1 inverse agonists |
| WO2019040122A1 (en) * | 2017-08-25 | 2019-02-28 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | COMPOSITIONS AND METHODS FOR ALLEVIATING PAIN |
| CN108299255B (zh) * | 2018-02-11 | 2020-05-19 | 山东大学 | 组蛋白去乙酰化酶8选择性抑制剂及其制备方法和应用 |
-
2018
- 2018-03-12 WO PCT/US2018/022029 patent/WO2019040122A1/en not_active Ceased
- 2018-03-12 US US16/641,401 patent/US11458142B2/en active Active
- 2018-03-12 CA CA3073801A patent/CA3073801C/en active Active
- 2018-03-12 BR BR112020003705-2A patent/BR112020003705B1/pt active IP Right Grant
- 2018-03-12 KR KR1020207005413A patent/KR102584483B1/ko active Active
- 2018-03-12 PL PL18847873.9T patent/PL3672938T3/pl unknown
- 2018-03-12 AU AU2018319549A patent/AU2018319549C1/en active Active
- 2018-03-12 RS RS20231074A patent/RS65171B1/sr unknown
- 2018-03-12 MX MX2020002147A patent/MX2020002147A/es unknown
- 2018-03-12 HR HRP20231564TT patent/HRP20231564T1/hr unknown
- 2018-03-12 CN CN201880069764.2A patent/CN111278805B/zh active Active
- 2018-03-12 JP JP2020532541A patent/JP7116792B2/ja active Active
- 2018-03-12 ES ES18847873T patent/ES2965542T3/es active Active
- 2018-03-12 HU HUE18847873A patent/HUE066993T2/hu unknown
- 2018-03-12 EP EP18847873.9A patent/EP3672938B1/en active Active
- 2018-03-12 SM SM20240050T patent/SMT202400050T1/it unknown
-
2020
- 2020-01-09 US US16/738,439 patent/US11007199B2/en active Active
-
2021
- 2021-01-08 WO PCT/US2021/012727 patent/WO2021142282A1/en not_active Ceased
- 2021-05-17 US US17/322,606 patent/US11529355B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015521617A5 (enExample) | ||
| JP2020533402A5 (enExample) | ||
| JP2007533686A5 (enExample) | ||
| JP2021120379A5 (enExample) | ||
| JP2016534063A5 (enExample) | ||
| JP2002524498A (ja) | 機能性及び／又は器質性痛み症候群の治療のための製薬組成物の調製のためのアセチルコリンエステラーゼ阻害剤の使用 | |
| JP2017513824A5 (enExample) | ||
| JP2008534453A5 (enExample) | ||
| JP2016507500A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2005531612A (ja) | ネフォパムの製剤および痛みの治療におけるその使用 | |
| JP2019531286A5 (enExample) | ||
| HRP20231564T1 (hr) | Spojevi za ublažavanje boli | |
| WO2023155837A1 (zh) | 具有镇痛和/或止痒功能的药物组合物及其用途 | |
| US20170319519A1 (en) | Combination for the treatment of conditions involving muscular pain | |
| RU2017137008A (ru) | Антагонисты толл-подобного рецептора 4 и применение при аутоиммунных заболеваниях печени | |
| CN109310669B (zh) | 氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途 | |
| CN109758452A (zh) | 胺类化合物治疗疼痛的医药用途 | |
| RU2008108175A (ru) | Комбинация соединений, которые можно использовать при лечении респираторных заболеваний, особенно хронической оструктивной болезни легких (copo) и астмы | |
| HUP0102987A2 (hu) | Hatóanyagként asztrocita funkciójavító szert tartalmazó készítmény Parkinson-kór kezelésére | |
| BR112013000164B1 (pt) | Agente terapêutico ou agente profilático | |
| JP2013518061A5 (enExample) | ||
| JP2010280699A (ja) | 双極性障害を処置するための医薬を得るためのアゴメラチンの使用 | |
| JP2017526719A5 (enExample) | ||
| CN101663036B (zh) | 4-环丙基甲氧基-n-(3,5-二氯代-1-氧代-4-吡啶-4-基)-5-(甲氧基)吡啶-2-甲酰胺用于治疗颅脑创伤的用途 |